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Abstract
Background: Human Papillomavirus (HPV) is considered as a necessary, but not sufficient, cause of cervical cancer. In
this study, we aimed to assess the prevalence of HPV in a series of pre-malignant and malignant cervical lesion cases, to
identify the virus genotypes, and to assess their distribution pattern according to lesion type, age range, and other
considered variables. The samples were submitted to histopathological revision examination and analysed by
polymerase chain reaction (PCR) for the presence of HPV DNA, followed by HPV typing by dot blot hybridisation.
Findings: Of the analysed samples, 53.7% showed pre-malignant cervical lesions, and 46.3% presented with
cervical cancer. Most cancer samples (84.1%) were classified as invasive carcinoma. The mean age of these cancer
patients was 47.3 years. The overall HPV prevalence was 82.4% in patients with pre-malignant lesions and 92.0% in
the cancer patients. HPV 16 was the most prevalent type, followed by HPV 18 and 58, including both single and
double infections. Double infection was detected in 11.6% of the samples, and the most common combination
was HPV 16+18.
Conclusions: Cervical cancer appears to occur in women in a lower age range in the studied area, compared to
the situation in other Brazilian regions. Furthermore, among the patients with CIN 3 and those with cancer, we
observed a higher proportion of married women, women with more than one sexual partner, smokers, and
individuals with less than an elementary education, relative to their counterparts.
Findings: The overall HPV prevalence was 82.4% in patients with pre-malignant lesions and 92.0% in the cervical
cancer patients from Northeast Brazil. HPV 16 was the most prevalent type, followed by HPV 18 and 58. The most
common double infection was HPV 16+18. Cervical cancer appears to occur in women in a lower age range in the
Northeast Brazil. Among the patients with CIN 3 and those with cancer, we observed a higher proportion of
married women, women with more than one sexual partner, smokers, and individuals with less than an elementary
education, relative to their counterparts.
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Squamous cell cervical carcinoma is the third most
common malignancy among women around the world,
especially in underdeveloped countries, and it is the sec-
ond cause of cancer death in women worldwide [1-3]. It
is now widely accepted that human papillomavirus
(HPV) infection of the cervical epithelium is a necessary,
but not sufficient, cause of the development of cervical
cancer, as well as a significant proportion of other ano-
genital and oral squamous cell carcinomas [4-6]. More
than 120 different HPV types have been catalogued so
far, and about 40 can infect the epithelium of the ano-
genital tract and other mucosal areas of the body. At
least 15 of them, called oncogenic or high-risk HPV
(HR-HPV), are strongly associated with progression to
invasive cervical cancer [5,7,8].
In Brazil, the occurrence of cervical cancer continues
to be a serious public health problem, showing remark-
able differences in incidence among different regions of
the country [9,10]. Archival formaldehyde-fixed, paraf-
fin-embedded tissues are an important source for retro-
spective studies of HPV detection to contribute further
to the implementation of public health measurements
for the management and control of cervical cancer
[11,12].
We have analysed a large series of cervical specimens
of archival formaldehyde-fixed, paraffin-embedded tis-
sues from women in a high-risk area for cervical cancer
in northeastern Brazil. The samples were re-examined,
and the lesions were histologically classified and ana-
lysed by polymerase chain reaction (PCR) for the pre-
s e n c eo fH P V ,f o l l o w e db yH P Vt y p i n gb yd o tb l o t
hybridisation.
Methods
A series of pre-malignant and malignant samples
obtained from archival paraffin-embedded tissues were
analysed. Initially, we selected specimens that had been
collected between January 1996 and December 2000
from patients with a previous diagnosis of cervical
lesions, treated at Luis Antonio Hospital, a cancer refer-
ral centre in the city of Natal, State of Rio Grande do
Norte (RN), Brazil. Six serial 5-μms e c t i o n sf r o me a c h
block were prepared: one was used for histopathological
revision examination, while the remaining samples were
processed for HPV DNA detection. After histopathologi-
cal revision, we selected 215 samples diagnosed with
severe cervical intraepithelial neoplasia (CIN 3) or cervi-
cal cancer, among which 9 cases were excluded due to
the lack of representative neoplastic tissue in the block
after histopathological evaluation, and 16 more were
excluded due to the lack of amplifiable DNA, leaving a
total of 190 samples for this study.
This study was approved by the Ethical Committee in
Research at the Federal University of Rio Grande do
Norte.
DNA extraction
DNA was extracted as previously described by Banerjee
et al. (1995) [13], with some minor modifications,
including the substitution of Triton X-100 with Tween
20 in the digestion buffer.
HPV DNA detection and typing
DNA samples were submitted to PCR analysis with the
b-globin primers, PCO3/PC04 [14]. The resulting 110-bp
amplicon served as an internal control to evaluate the
integrity and sufficiency of the DNA extracted from cer-
vical specimens. For HPV DNA detection, the generic
primers, GP5+/GP6+, were used to amplify a fragment of
about 140 bp [15]. PCR products were typed by dot-blot
hybridisation, according to the method of Manos et al.
(1989) [16].
Statistical analyses
To verify the association between HPV prevalence and
the considered variables, the c
2 test and the proportion
comparison test were performed using the Statistica 7.0
software. Values of p ≤ 0.05 were considered as statisti-
cally significant.
Results
The presence of cervical lesions was confirmed in 206 of
the 215 samples analysed by histopathological revision
exam; these samples were then submitted to DNA
extraction for molecular analysis. Among all of the sam-
ples, 190 were positive for the amplification of a human
b-globin gene segment. Among them, 53.7% showed
pre-malignant lesions classified as severe CIN 3; 38.9%
presented with invasive squamous cell carcinoma (SCC);
and 7.4% were classified as adenosquamous carcinoma
(ADSQ).
Among the samples with only malignant lesions, most
(84.1%) were histologically classified as SCC, whereas only
15.9% were categorised as ADSQ. We verified that the
majority of the samples (60.0%) were obtained from non-
Caucasian women (African-mixed-descendant) considered
as non-white in this study, whereas 40.0% of the samples
were from Caucasians considered as white. The age varied
from 19 to 69 years, with a mean age of 44.3 ± 11.25 years
for patients with CIN 3 and 47.3 ± 10.9 years for those
with cervical cancer. Most of the CIN 3 samples (61.7%)
were obtained from women between 19 and 47 years of
age, while most of the cervical cancer samples (86.4%)
were obtained from patients between 38 and 57 years of
age (Table 1).
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Page 2 of 6In patients with CIN 3 or cancer, we observed a
higher proportion of married women (p = 0.000, p =
0.001), women with more than one sexual partner in
their lifetime (p = 0.000, p = 0.000), smokers (p = 0.010,
p = 0.001), and individuals with less than an elementary
education (p = 0.039, p = 0.023), relative to their coun-
terparts. Moreover, we observed a higher incidence
of cancer among the non-white women (p = 0.002)
(Table 1).
Of the 190 samples positive for b-globin, 165 were
also positive for the amplification of a target sequence
of the HPV genome, revealing an overall HPV preva-
lence of 86.8% (Table 2).
Among the HPV-positive samples, 86.7% had a single
infection, while 13.3% had a double infection. When
each lesion type was considered separately, the observed
HPV prevalence rate was 82.4% for CIN 3, 91.9% for
SCC, and 92.9% for ADSQ. When both single and dou-
ble infections were considered, HPV 16 was the most
common HPV type, with a prevalence rate of 60.5% for
overall patients, 61.8% for CIN 3, 64.9% for SCC, and
28.6% for ADSQ, followed by HPV 18 with a prevalence
rate of 10.5% for overall patients, 7.8% for CIN 3, 4.1%
Table 1 Distribution of HPV prevalence according to the lesion types and considered variables.
CIN 3 (n = 102) Cervical cancer (n = 88)
Variables No. of Samples (%) No. of samples with HPV (%) No. of samples (%) No. of samples with HPV (%)
Age at study entry
≤ 37 14 (13.7) 11 (78.6) 14 (15.9) 13 (92.9)
38 - 47 49 (48.0) 41 (83.7) 40 (45.5) 37 (92.5)
48 - 57 28 (27.5) 23 (82.1) 22 (25.0) 20 (90.9)
≥ 57 11 (10.8) 9 (81.8) 12 (13.6) 11 (91.7)
Ethnicity
White 45 (44.1) 37 (82.2) 31(35.2) 29 (93.5)
Non-white 57 (55.9) 47 (82.5) 57(64.8) 52 (91.2)
Marital status
Single 30 (29.4) 25 (83.3) 29 (33.0) 27 (93.1)
Married 61 (59.8) 50 (82.0) 52 (59.0) 48 (92.3)
Other 11 (10.8) 9(81.8) 7 (8.0) 6 (85.7)
Education
Less than elementary 56 (54.9) 46 (82.1) 49 (55.7) 45 (91.8)
Elementary 40 (39.2) 33 (82.5) 34 (38.6) 31 (91.2)
High school 6 (5.9) 5 (83.3) 5 (5.7) 5 (100.0)
More than one partner
Yes 70 (68.6) 58 (82.9) 58 (65.9) 54 (93.1)
No 32 (31.4) 26 (81.2) 30 (34.1) 27 (90.0)
Smoking
Yes 61 (59.8) 50 (82.0) 56 (63.6) 52 (92.9)
No 41 (40.2) 34 (82.9) 32 (36.4) 29 (90.6)
HPV Positive 84 (82.4) 81 (92.0)
HPV Negative 18 (17.6) 7 (8.0)
Total 102 (100) 88 (100)
CIN - cervical intraepithelial neoplasia
Table 2 Distribution of HPV genotypes according to
lesion types
Lesion Types
CIN 3 SCC ADSQ
HPV Genotype No. (%) No. (%) No. (%)
16 53 (52.0) 45 (60.8) 2 (14.3)
58 5 (4.9) 7 (9.5)
18 3 (2.9) 2 (4.1) 7 (50.0)
45 2 (2.0) 2 (2.7) 2 (14.3)
31 2 (2.0) 2 (2.7)
33 2 (2.0) 2 (2.7)
52 1 (1.0) 1 (1.3)
59 2 (2.00 1 (1.3)
16 + 18 5 (4.9) 1 (1.3) 2 (14.3)
31 + 33 3 (2.9) 2 (2.7)
16 + 31 3 (2.9) 1 (1.3)
16 + 52 1 (1.0) 1 (1.3)
58 + 56 1 (1.0) 1 (1.3)
Positive 84 (82.4) 68 (91.9) 13 (92.9)
Negative 18 (17.6) 6 (8.1) 1 (7.1)
Total 102 (100) 74 (100) 14 (100)
CIN - Cervical intraepithelial neoplasia, SCC - Squamous cell carcinoma, ADSQ
- Adenosquamous carcinoma
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Page 3 of 6for SCC, and 64.3% for ADSQ. HPV 58 followed with a
prevalence rate of 7.4% for overall patients, 5.9% for
CIN 3, 10.8% for SCC, and 0.0% for ADSQ. HPV double
infection was detected in 11.6% of the samples, with a
prevalence rate of 13.7% for CIN 3, 8.1% for SCC, and
14.3% for ADSQ. The most common combination of
HPV double infections was HPV 16+18. When only the
samples with cervical cancer, including single and dou-
ble infections, were considered, the distribution of the
most common HPV type in terms of prevalence rate, in
decreasing order, was as follows: HPV 16, followed by
HPV 18, 58, 31, 45, and 33 (Table 2).
We found statistically significant differences in the
prevalence rates of HPV 16 and HPV 18 between the
samples with CIN 3 and those with ADSQ (c
2 = 24.76,
p < 0.001). Similar differences were found between the
samples with SCC and those with ADSQ (c
2 = 27.29,
p < 0.001) (Table 3).
Discussion
The majority of the samples with cervical malignant
lesions analysed in this study (84.1%) were histologically
classified as SCC, while ADSQ was found in the remain-
ing 15.9% of cases, a ratio similar to that described by
the National Institute of Cancer, Brazil [10]. Considering
that the specimens used in this study were fixed in non-
buffered formalin, a 92.2% yield of amplifiable DNA can
be considered as satisfactory.
The average age of the cervical cancer patients in this
study was 47.3 years, which is lower than that of Brazi-
lian women from other regions of the country, such as
central (49 years) [9], northern (51 years) [17], and
southeastern (52 years) Brazil [18]. This mean age of
cervical cancer occurrence was higher than the reported
average for six African countries (33.9 years) but was
lower than that for three European countries (56.5
years) [1]. We observed that 61.4% of the patients with
cervical cancer were up to 47 years of age and 15.9%
were up to 37 years of age. This relatively high fre-
quency of cervical cancer in young women could be due
to the acquisition of high-risk HPV infection at a young
age among the local female population. This hypothesis
is in agreement with a previous study of the Natal-RN
population conducted by Fernandes et al., (2008) [19]
and a systematic review written by Smith et al. (2007)
[20]. It is also likely that there are some high-risk HPV
variants with an increased oncogenic potential circulat-
ing in northeast Brazil. Other factors that might also
contribute to the low mean age of the cervical cancer
patients found in this study are a low degree of educa-
tion, a low socio-economic status, sexual behaviour, and
failure of the screening programmes in preventing and
controlling cervical cancer.
We observed a high incidence of cervical cancer in the
non-white women. However, due to the high degree of
interbreeding in the population of Rio Grande do Norte
[21], the impact of ethnicity on the results of this study
is difficult to assess.
We also found a high incidence of cervical cancer in
married women, women with a low degree of education,
w o m e nw i t hm o r et h a no n es e x u a lp a r t n e ri nt h e i rl i f e -
time, and smokers.
The overall HPV prevalence in cancer samples in this
study was 92.0%, higher than that described for women
from Goiânia, in the central region of Brazil (80.3%) [9].
Six types of HPV, all high-risk, were identified. HPV 16
was the most prevalent type in the samples with CIN 3
and SCC. HPV 18 was the most prevalent type in those
with ADSQ. These results are consistent with those
described in the literature [20,22,23].
Comparing the distribution of HPV types by preva-
lence order with that in other regions of Brazil, as
described by Rabelo-Santos et al. (2003), the overall
H P V1 6p r e v a l e n c er a t ef o u n di nt h ec u r r e n ts t u d y
(59.1%) was similar to that described for the central
region (57.1%), almost equal to that described for the
northeastern region (59.3%), but higher than that in the
southern (52.2%), southeastern (53.8%), and northern
regions (43.5%). The HPV 18 prevalence was higher
than that reported for all other regions of the country,
including the northeastern region. With regard to HPV
31, the prevalence rate observed in the present study
was higher than that described for the central region,
similar to that in the southern and southeastern regions,
and lower than that described for the northeastern
region. The HPV 33 prevalence rate found in this study
was lower than that reported for the central, southern,
and southeastern regions but similar to that for the
northeastern region. However, these results of genotype
distribution might also be influenced by the HPV geno-
typing techniques used in the different studies.
When only considering cancer cases and by comparing
the prevalence rates of HPV types with a consistent
worldwide study conducted by Bosch et al., 1995 [1], we
found that the HPV 16 prevalence rate in the current
study was similar to that found in Brazil (52.2%), higher
Table 3 Distribution differences of the genotypes, HPV
16 and HPV 18 in CIN 3 and cervical cancer, including
single and multiple infections.
HPV
16
HPV
18
Χ
2
test
p
Diagnosis N Positive Negative
CIN 3 102 84 18 63 8 24.76 0.000*
SCC 74 68 6 48 3 27.29 0.000*
ADSQ 14 13 1 4 9 - -
CIN - Cervical intraepithelial neoplasia, SCC - Squamous cell carcinoma, ADSQ
- Adenosquamous carcinoma *Statistically Significant
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and that of six South American countries (50.4%), and
lower than the mean described for three European coun-
tries (65.1%). HPV 18 was second in prevalence, found in
13.6% of the cancer samples; its prevalence rate was
higher than that of Brazil (8.7%), as well as that of South
American (8.8%) and European (8.1%) countries, but it
was lower than the prevalencer a t eo ft h eA f r i c a nc o u n -
tries (17.7%). HPV 58 was detected in 9.1% of the sam-
ples, with a prevalence rate three times higher than the
mean of the African countries (2.7%), four times higher
than the mean of the Central and South American coun-
tries (2.2%), and seven times higher than the mean of the
European countries (1.2%). A high HPV 58 prevalence
was also described in patients with cervical pre-malignant
lesions in the southern region of Brazil [24].
Geographical differences in HPV distribution of cervi-
cal cancer have recently been compiled [2,8] and serve
as the basis for the implementation of cervical cancer
control strategies around the world [25].
Conclusions
Cervical cancer appears to occur in a lower age-range in
women in this study, when compared with studies con-
ducted in other Brazilian regions. Among the patients
with CIN 3 and cancer, we observed a higher proportion
of married women, women with more than one sexual
partner, smokers, and individuals with less than an ele-
mentary education, relative to their counterparts.
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